Back to Search
Start Over
Supplementary Figure 1 from A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 29K, Chemical structures of sonidegib and cyclopamine.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....32c2cdb2ec08f0741538518a6fa3b997